The Vanguard Group 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:19 am Sale |
2022-12-30 | 13G | G1 Therapeutics, Inc. GTHX |
The Vanguard Group | 1,925,845 3.810% |
-618,520 (-24.31%) |
Filing |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
The Vanguard Group | 2,544,365 5.980% |
448,638 (+21.41%) |
Filing |
| 2021-02-10 10:57 am Purchase |
2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
The Vanguard Group | 2,095,727 5.510% |
82,162 (+4.08%) |
Filing |